Ledger.Open graph →
SEC Form D · filed April 17, 2024

RheumaGen, Inc

Offering
$15.0M
Sold
$4.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DENVER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Thomas M. Fratacci · Denver, CODirectorBobak R. Mozayeni · Denver, COExecBruce M. Goodwin · Denver, CODirectorRichard A. Freed, Iii · Denver, COExec · DirectorRyan K. Hart · Denver, COExecJames B. Hart, Jr · Denver, COExecBrian M. Freed · Denver, COExecBruce M. Goodwin · Denver, CODirectorJames B. Hart, Jr · Denver, COExecRichard A. Freed, Iii · Denver, COExec · DirectorThomas M. Fratacci · Denver, CODirectorRyan K. Hart · Denver, COExecBrian M. Freed · Denver, COExecBobak R. Mozayeni · Denver, COExecPeter Tague · Santa Clara, CADirectorMatthew W. Gorham · San Francisco, CAExecBuckland Connor · Yakima, WAExecHansel Rodriguez · Miami, FLExecSam Ellis · Grand Cayman, Cayman IslandsDirectorSherri Fleming · Grand Cayman, Cayman IslandsExecJason Richardson · Birmingham, ALExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗